Canadian CP Registry - Registre Canadien de la Paralysie Cérébrale
Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE · Nov 22, 2017
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
The Canadian Cerebral Palsy Registry is a multi-regional Canadian registry to identify potential risk factors related to pregnancy and interactions of the environment and genetics. The Registry provides researchers with the approximate number of children with cerebral palsy across Canada, and data in the Registry helps researchers explore reasons behind the causes of cerebral palsy, in addition to supporting studies which may lead to improvements in the overall care of children with CP.
Cerebral palsy is the most common cause of physical disability in children in Canada and it is important...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Under 18 (age cut-off varies by region)
- • Diagnosed with Cerebral Palsy
- • Living in Canada
- Exclusion Criteria:
- • Uncertain CP diagnosis
About Mcgill University Health Centre/Research Institute Of The Mcgill University Health Centre
The McGill University Health Centre (MUHC) and the Research Institute of the McGill University Health Centre (RI-MUHC) are leading institutions in clinical research and healthcare innovation. With a commitment to advancing medical knowledge and improving patient outcomes, the MUHC integrates cutting-edge research with high-quality patient care. The RI-MUHC fosters a collaborative environment where multidisciplinary teams engage in transformative research across various fields, including oncology, neurology, and cardiovascular health. By leveraging state-of-the-art facilities and a robust network of clinical expertise, both entities strive to translate scientific discoveries into effective treatments, ultimately enhancing the quality of life for patients locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Edmonton, Alberta, Canada
Calgary, Alberta, Canada
Montréal, Quebec, Canada
Vancouver, British Columbia, Canada
St. John's, Newfoundland & Labrador, Canada
Barrie, Ontario, Canada
Toronto, Ontario, Canada
Gatineau, Quebec, Canada
Joliette, Quebec, Canada
Montréal, Quebec, Canada
Montréal, Quebec, Canada
Montréal, Quebec, Canada
Quebec City, Quebec, Canada
Sherbrooke, Quebec, Canada
Patients applied
Trial Officials
Michael I Shevell, MDCM
Principal Investigator
McGill University Health Centre/Research Institute of the McGill University Health Centre
Maryam Oskoui, MD, MSc
Principal Investigator
McGill University Health Centre/Research Institute of the McGill University Health Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials